Smith CJ - Search Results

1

Physical and psychological symptoms and risk of virologic rebound among patients with virologic suppression on antiretroviral therapy.

Lampe FC, Harding R, Smith CJ, Phillips AN, Johnson M, Sherr L. Lampe FC, et al. Among authors: smith cj. J Acquir Immune Defic Syndr. 2010 Aug;54(5):500-5. doi: 10.1097/QAI.0b013e3181ce6afe. J Acquir Immune Defic Syndr. 2010. PMID: 20150819

2

The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy.

Smith CJ, Sabin CA, Lampe FC, Kinloch-de-Loes S, Gumley H, Carroll A, Prinz B, Youle M, Johnson MA, Phillips AN. Smith CJ, et al. AIDS. 2003 May 2;17(7):963-9. doi: 10.1097/00002030-200305020-00004. AIDS. 2003. PMID: 12700445

3

Acetyl-l-carnitine: a pathogenesis based treatment for HIV-associated antiretroviral toxic neuropathy.

Hart AM, Wilson AD, Montovani C, Smith C, Johnson M, Terenghi G, Youle M. Hart AM, et al. AIDS. 2004 Jul 23;18(11):1549-60. doi: 10.1097/01.aids.0000131354.14408.fb. AIDS. 2004. PMID: 15238773 Clinical Trial.

4

Use of viral load measured after 4 weeks of highly active antiretroviral therapy to predict virologic outcome at 24 weeks for HIV-1-positive individuals.

Smith CJ, Staszewski S, Sabin CA, Nelson M, Dauer B, Gute P, Johnson MA, Phillips AN, Gazzard B. Smith CJ, et al. J Acquir Immune Defic Syndr. 2004 Sep 1;37(1):1155-9. doi: 10.1097/01.qai.0000135958.80919.e4. J Acquir Immune Defic Syndr. 2004. PMID: 15319675

5

Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.

Smith CJ, Sabin CA, Youle MS, Kinloch-de Loes S, Lampe FC, Madge S, Cropley I, Johnson MA, Phillips AN. Smith CJ, et al. J Infect Dis. 2004 Nov 15;190(10):1860-8. doi: 10.1086/425075. Epub 2004 Oct 8. J Infect Dis. 2004. PMID: 15499544

6

Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy.

Sabin CA, Smith CJ, Gumley H, Murphy G, Lampe FC, Phillips AN, Prinz B, Youle M, Johnson MA. Sabin CA, et al. Among authors: smith cj. AIDS. 2004 Nov 5;18(16):2145-51. doi: 10.1097/00002030-200411050-00006. AIDS. 2004. PMID: 15577647

7

The problems faced when assessing the prevalence and incidence of antiretroviral-related toxicities.

Smith CJ, Sabin CA. Smith CJ, et al. Antivir Ther. 2004 Dec;9(6):865-78. Antivir Ther. 2004. PMID: 15651745 Review.

8

Does immune reconstitution syndrome promote active tuberculosis in patients receiving highly active antiretroviral therapy?

Breen RA, Smith CJ, Cropley I, Johnson MA, Lipman MC. Breen RA, et al. Among authors: smith cj. AIDS. 2005 Jul 22;19(11):1201-6. doi: 10.1097/01.aids.0000176221.33237.67. AIDS. 2005. PMID: 15990574

9

The rate of viral rebound after attainment of an HIV load <50 copies/mL according to specific antiretroviral drugs in use: results from a multicenter cohort study.

Smith CJ, Phillips AN, Hill T, Fisher M, Gazzard B, Porter K, Gilson R, Easterbrook P, Matthias R, Scullard G, Johnson MA, Sabin CA; United Kingdom Collaborative HIV Cohort Study Group. Smith CJ, et al. J Infect Dis. 2005 Oct 15;192(8):1387-97. doi: 10.1086/466534. Epub 2005 Sep 14. J Infect Dis. 2005. PMID: 16170756

10

Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers.

Sabin CA, Smith CJ, Youle M, Lampe FC, Bell DR, Puradiredja D, Lipman MC, Bhagani S, Phillips AN, Johnson MA. Sabin CA, et al. Among authors: smith cj. AIDS. 2006 Jan 2;20(1):67-71. doi: 10.1097/01.aids.0000196178.73174.24. AIDS. 2006. PMID: 16327321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,408 results

Search Page

Filters